Delivery Order SPE2DB22D2218-SPE2DB25FR3DG
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $6.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for REXULTI 3 MG tablets (30-count supply) with a ceiling value of $22,083.84. This firm fixed price delivery order represents a non-competitive set-aside contract and is scheduled for ultimate completion by August 8, 2025. The award is executed under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of REXULTI 1 mg tablets (30-count units) with a ceiling value of $10,390.65. This firm fixed-price delivery order, which is expected to complete by July 29, 2025, represents a non-set-aside competitive award and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. REXULTI is a prescription antipsychotic medication used to treat major depressive disorder and...
- The Defense Logistics Agency awarded a $10,248.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for REXULTI 1 mg tablets (30-count packages) with an ultimate completion date of July 24, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a delivery order valued at $111,754.45 to AmerisourceBergen Drug Corp for the supply of REXULTI 2 mg tablets (30-count units) under a firm fixed price arrangement. The award, issued on July 21, 2025, with completion scheduled for July 22, 2025, represents a non-competitive delivery against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for REXULTI 2 mg tablets (30-count packaging) under a firm fixed-price contract with a ceiling value of $1,849.52. The award was issued on August 15, 2025, with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB24FGF00) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of pharmaceutical products including REXULTI 1 mg tablets. The $1,819.86 contract has an ultimate completion date of March 21, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with a potential value...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product REXULTI 1 MG TABLET 30S. The contract, valued at $1,436.77, has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this award. This delivery order...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $5,173 to Amerisourcebergen Drug Corporation for 0.25 mg REXULTI tablets. Under this order, Amerisourcebergen will deliver 30 tablets to a location in Conshohocken, Pennsylvania by August 15, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen frequently receives delivery orders under the DLA's Pharmaceutical Prime Vendor contract to support the medical...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $30,807.50 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 30-count bottles of 1 mg REXULTI tablets. Performance will take place in Conshohocken, Pennsylvania under a single-day period from July 25-26, 2023. As the prime contractor, Amerisourcebergen will fulfill the Defense Logistics Agency's requirement for this atypical antipsychotic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Rexulti 1 mg tablets in a 30-count package, with a contract ceiling value of $4,260.21. This non-set-aside, competitively awarded delivery order represents a firm fixed price transaction and is scheduled for completion by August 15, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...